Two are the vaccines who have received approval and are safe to protect against the RSV respiratory virus.
According to the instructions of the Hellenic Pulmonary Society, it is recommended to vaccinate any of the available two vaccines (RSVPref3, RSVPref), which have been approved by the European Medicines Agency (EMA) in 2023 to protect from RSV:
– In all COPD patients, with particular emphasis on COPD patients and cardiovascular disease
– To all patients with asthma
– In all patients with cystic fibrosis, severe interstitial pulmonary disease, severe pulmonary hypertension
– In all patients over 50 years of age with co -consciousness [σακχαρώδη διαβήτη, καρδιαγγειακά νοσήματα (καρδιακή ανεπάρκεια, στεφανιαία νόσο, σοβαρές βαλβιδοπάθειες, υπέρταση, αγγειακή νόσο του εγκεφάλου), χρόνια νεφρική νόσο, χρόνια ηπατοπάθεια, συγγενή ή επίκτητη ανοσοκαταστολή]
– to all adults over 60 years of age with or without co -hosts
The EIA also stresses the importance of vaccination with RSVPref, for women who are pregnant to protect their newborns during the first 6 months of life, where the risk of severe RSV infection is increased. Vaccination is recommended to take place at 32 to 36 weeks of pregnancy, ensuring the transfer of antibodies from mother to fetus via the placenta. In this way the infant is protected immediately after birth, when it is particularly vulnerable. International studies have shown that pregnant vaccination is safe and significantly reduces infants due to RSV infection.
Information spot with favorite protagonists
“… RSV? What is RSV? “ Mirka Papaconstantinou wonders… and Pavlos Orkopoulos replies in an enigmatic style: “It is a respiratory virus that does not forgive negligence …”.
The two well -known and beloved actors of theater and television star in a spotlight on the Information and Awareness Campaign carried out by the Hellenic Pulmonary Society (EIA) on vaccination as a prevention measure against respiratory virus (RSV). Through a realistic but humorous style of dialogue, the viewer/listener explains what the RSV is and what categories of population the virus vaccination is recommended as a measure of prevention.
The message of the EIA campaign is: “Vaccination against RSV – Little Decision … Great Prevention step! Please be informed by your doctor »
“The campaign aims to inform and remind adults over 60 years of age, vulnerable groups but also to women who are pregnant, that there is no treatment for respiratory virus to deal with respiratory virus, except for prevention through vaccination,” said the President of the Hellenic Society. Stelios Loukidis.
He added that “to date the data we have at our disposal states that the effect of respiratory virus as an endemic viral infection during the November -February has a significant impact on the health system with several hospitalizations and unfortunately with high mortality.”
The Secretary General of the Hellenic Pulmonary Society Professor of Pulmonology of the NCSR, Petros Bakakoshe said that “RSV presents elderly adults and patients with chronic diseases, especially respiratory and cardiovascular system, high rates of serious complications and adverse outcomes of the viral infection similar to those of influenza, and is considered the second most commonly recognized cause.”